Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transcatheter Arterial Chemoembolization”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Testing effectiveness (Phase 2)UnknownNCT04157140
What this trial is testing

Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Jinglong Chen 48
Not applicableUnknownNCT05811481
What this trial is testing

Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy

Who this might be right for
Hepatocellular CarcinomaTranscatheter Arterial ChEmoembolizationRegorafenib
WenBo Guo 192
Not applicableUnknownNCT03066557
What this trial is testing

Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Jiangsu Cancer Institute & Hospital 80
Not applicableStudy completedNCT02728219
What this trial is testing

Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion

Who this might be right for
Recurrent Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 150
Not applicableLooking for participantsNCT06669377
What this trial is testing

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 444
Early research (Phase 1)UnknownNCT04592029
What this trial is testing

TACE Combined With Sintilimab and Bevacizumab for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 36
Not applicableLooking for participantsNCT06740370
What this trial is testing

TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTranscatheter Arterial ChemoembolizationAnti-PD1 Antibody+1 more
Sun Yat-sen University 32
Post-approval studies (Phase 4)UnknownNCT05416073
What this trial is testing

Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTransarterial ChemoembolizationHepatic Arterial Infusion Chemotherapy+1 more
The Second Affiliated Hospital of Chongqing Medical University 70
Large-scale testing (Phase 3)Ended earlyNCT01465464
What this trial is testing

Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Taiho Pharmaceutical Co., Ltd. 888
Testing effectiveness (Phase 2)UnknownNCT02956772
What this trial is testing

Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Primary Hepatocellular Carcinoma
Hunan Provincial People's Hospital 190
Not applicableLooking for participantsNCT06487663
What this trial is testing

TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors

Who this might be right for
Hepatocellular Carcinoma Non-resectableCholangiocarcinoma Non-resectableLiver Metastases+1 more
Tianjin Medical University Cancer Institute and Hospital 40
Not applicableUnknownNCT03191123
What this trial is testing

Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor

Who this might be right for
Carcinoma, HepatocellularSurvival Rate
Huazhong University of Science and Technology 100
Not applicableActive Not RecruitingNCT07065786
What this trial is testing

A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted Therapy

Who this might be right for
Transcatheter Arterial ChemoembolizationUnresectable Hepatocellular Carcinoma
Zhongda Hospital 550
Testing effectiveness (Phase 2)Looking for participantsNCT04954781
What this trial is testing

TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University 25
Large-scale testing (Phase 3)UnknownNCT03783559
What this trial is testing

TACE(Transcatheter Arterial Chemoembolization ) Associated With Systemic Chemotherapy Versus Systemic Chemotherapy Alone in Patients With Unresectable CRLM(Colorectal Liver Metastases)

Who this might be right for
Colorectal Adenocarcinoma Metastatic to the Liver
Fudan University 168
Post-approval studies (Phase 4)UnknownNCT00556803
What this trial is testing

TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Sun Yat-sen University 120
Large-scale testing (Phase 3)Study completedNCT03636620
What this trial is testing

TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial

Who this might be right for
Hepatocellular Carcinoma
Fudan University 110
Large-scale testing (Phase 3)UnknownNCT02987907
What this trial is testing

The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 220
Post-approval studies (Phase 4)UnknownNCT01959061
What this trial is testing

Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer Metastatic
Nanjing Chia-tai Tianqing Pharmaceutical 320
Not applicableUnknownNCT00563095
What this trial is testing

A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
Hospital Authority, Hong Kong 100
Load More Results